Education
About Us
Working with TipRanks
Follow Us
Redcare Pharmacy (DE:RDC)
XETRA:RDC
RDC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€86.20 - €171.40
Previous CloseN/A
Volume73.26K
Average Volume (3M)159.17K
Market Cap
€1.95B
Enterprise Value€654.84M
Total Cash (Recent Filing)€177.56M
Total Debt (Recent Filing)€247.38M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Jul 29, 2025EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.52
Shares Outstanding20,578,390
10 Day Avg. Volume120,181
30 Day Avg. Volume159,172
Financial Highlights & Ratios
PEG Ratio43.72
Price to Book (P/B)2.44
Price to Sales (P/S)0.00
P/FCF Ratio-12.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€165.60Price Target Upside72.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Redcare Pharmacy News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSales were up 28% to €717 million, driven by growth in the OTC segment and strong German Rx sales.
Market ShareThe company's market share increased to 0.87%.
Bears Say
ProfitabilityThe intensified marketing efforts for Rx came at a cost of slightly lower profitability in FY24.
Sales MomentumGerman Rx sales showed a sequential slowdown, with only €6m incremental sales.
Options Prices
Currently, No data available
---
Ownership Overview
4.37% Insiders
12.32%
Mutual Funds
<0.01% Other Institutional Investors
76.64% Public Companies and
Individual Investors
RDC FAQ
What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest stock price was €86.20 and its highest was €171.40 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Redcare Pharmacy’s market cap is €1.95B.
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s upcoming earnings report date is Jul 29, 2025 which is in 23 days.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on May 06, 2025. The company reported -€0.515 earnings per share for the quarter, beating the consensus estimate of -€0.717 by €0.202.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is -0.21.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,578,390 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of -€0.515 in its last earnings report, beating expectations of -€0.717. Following the earnings report the stock price went down -7.687%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in DE:RDC
Redcare Pharmacy Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€165.60 (72.86% Upside)
€165.60 (72.86% Upside)
Insider Transactions
Bought Shares
Worth €898.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.87%
12-Months-Change
Fundamentals
Return on Equity
-9.80%
Trailing 12-Months
Asset Growth
0.84%
Trailing 12-Months
Company Description
Redcare Pharmacy
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
RDC Stock 12 Month Forecast
Average Price Target
€165.60
▲(72.86%Upside)